1. Han, S.Y.; Chang, S. InHandbook of Metathesis; Grubbs, R. H., Ed.; Wiley-VCH: Weinheim, 2003; Vol. 2, pp 5−127.
2. Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061
3. Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans
4. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
5. Donsbach, K.; Ecker, D.; Frutos, R. P.; Gallou, F.; Gutheil, D.; Haddad, N.; Hagenkötter, R.; Kemmer, D.; Kröber, J.; Nicola, T.; Schnaubelt, J.; Schul, M.; Simpson, R. D.; Wei, X.; Winter, E.; Xu, Y.; Yee, N. (Boehringer Ingelheim) PCT Int. Appl. WO 04092203, 2004.